Síndrome de Sweet asociado a leucemia mieloide aguda y factor estimulante de colonias de granulocitos: Caso clínico

N, Montserrat Molgó; F, Pilar de la Sotta; F, Laura Giesen; B, Sergio González

doi:10.4067/s0034-98872011001200009

Rev. méd. Chile

2011

DOI: 10.4067/s0034-98872011001200009

|View full text |Cite

Síndrome de Sweet asociado a leucemia mieloide aguda y factor estimulante de colonias de granulocitos: Caso clínico

Montserrat Molgó N

Pilar de la Sotta F

Laura Giesen F

et al.

Abstract: (Rev Med Chile 2011; 139: 1592-1596).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2012

2019

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 11 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Filgrastim

2012

Reactions Weekly

View full text Add to dashboard Cite

S Filgrastim Sweet's syndrome: case reportA 53-year-old woman developed Sweet's syndrome while receiving filgrastim.The woman was receiving filgrastim [dosage and route not stated] as adjuvant therapy to manage febrile neutropenia, after being diagnosed with acute myeloid leukaemia. In addition, she was receiving induction chemotherapy with daunorubicin and cytarabine. She developed an increase in lesions in the form of blisters and haemorrhagic pustules, surrounded by sensitive inflammatory plaques on her limbs, neck and face, 13 days after chemotherapy. The lesions were associated with arthralgia, myalgia and high fever. She had headaches and developed conjunctivitis and erosions affecting her mucous membranes and tongue, associated with gingival hyperplasia. Findings of a biopsy of her cutaneous lesions were consistent with Sweet's syndrome.The woman started IV hydrocortisone; her cutaneous lesions improved significantly. However, she died due to respiratory and heart failure before the start of the second chemotherapy cycle. No autopsy was carried out.

show abstract

Filgrastim

2012

Reactions Weekly

View full text Add to dashboard Cite

show abstract

Síndrome de Sweet mielodisplásico corticodependiente. A propósito de un caso

García

Torre

Prados

et al. 2019

Revista del Laboratorio Clínico

View full text Add to dashboard Cite

Síndrome de Sweet de presentación atípica asociado a sífilis secundaria

Braga

Ortíz

Aldama

et al. 2014

Piel

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Síndrome de Sweet asociado a leucemia mieloide aguda y factor estimulante de colonias de granulocitos: Caso clínico

Abstract: (Rev Med Chile 2011; 139: 1592-1596).

Cited by 3 publications

References 11 publications

Filgrastim

Filgrastim

Síndrome de Sweet mielodisplásico corticodependiente. A propósito de un caso

Síndrome de Sweet de presentación atípica asociado a sífilis secundaria

Contact Info

Product

Resources

About